← Eichor
Study identifier: NCT06820034 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Empowering Cessation ACS South Region

Condition: Smoking Cessation  ·  Sponsor: University of Oklahoma

PhasePhase 2/Phase 3
Planned participants400
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersYes

About this study

Sexual and/or gender minority (SGM) people face a disproportionate burden of cancer risk, and tobacco use is a key modifiable risk factor. SGM tobacco-related disparities are especially pronounced in places with high levels of stigma against SGM people. This community-engaged and remotely-delivered Research Scholar Grant project will evaluate an empowerment-based smoking cessation intervention tailored for SGM people in high-stigma places. In partnership with Freedom Oklahoma (OK) and a Community Advisory Board from Arkansas (AR) and Texas (TX) this projects aims to: (1) Adapt SGM-serving volunteer activities from the Oklahoma intervention pilot study for delivery in nearby states; (2) Test intervention efficacy among SGM adults in OK, AR, and TX; (3) Identify treatment mechanisms.

This description comes directly from the study's public registry record.

Talk to the study team

Julia McQuoid, PhD  ·  405-271-6872  ·  julia-mcquoid@ouhsc.edu

David Bradley, BA  ·  405-934-6811  ·  david-bradley@ou.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Oklahoma Health CampusOklahoma City, Oklahoma, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06820034